Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Analysts

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Analysts

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) has earned an average rating of "Moderate Buy" from the twenty-one brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating,